Natus

Natus Medical Incorporated is a provider of healthcare products, which are used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. It operates worldwide over 80 countries. Natus has eight subsidiaries. The company is headquartered in California, the US. In October 2008, Natus Medical completed the acquisition of privately-held NeuroCom International, Inc., for a purchase cost of $18 million. Also in October 2008, the company has agreed to acquire certain assets from BrainZ Instruments Limited Global Market Direct’s Natus Medical Incorporated. 

With idsMED, Natus has ALGO Newborn Hearing Screeners to detect the quality of newborn life. By allowing for early detection and treatment, they believe their products can improve clinical outcomes, help reduce costs, and minimize the duration of treatment, unnecessary retesting, or hospital readmission. 

Founded in 1989, Natus Medical Incorporated is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. Their mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions. 

Products manufactured by Natus are sold through a combination of a direct sales force and worldwide distribution partners. Natus products are sold and supported in over 100 countries. Among the many benefits provided to their customers is the NERVE Center, Natus’ education portal supporting their customers with ongoing product and clinical training and education.